Objective: Compare the benefits of Kinesio Taping and Inhibitory Treatment Techniques for Cervical, Thoracic and Lumbar Spine in Patients with Fibromyalgia Syndrome (FMS). Study Design: A single-blind randomized controlled trial was conducted on patients with FMS. Setting: Clinical setting. Methods: Sixty-four subjects with FMS were randomly assigned to an experimental group receiving kinesio taping and inhibitory treatment techniques, or to a control group for exercises and electrical stimulation therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
64
Kinesio Taping on trapezius, infraspinatus, and paravertebral muscles Inhibitory Treatment Techniques: * Release Technique of the trapezius muscle. * Release Technique for scalene muscles. * Technique suboccipital inhibition. * Technique hands crossed for induction dorsal superficial fascia.
Session for general physical activities (joint mobility, muscle strength and elasticity), and electrical stimulation therapy on para vertebral muscles.
Adelaida María Castro-Sánchez
Almería, Spain
Pain Intensity
A 10-point Numerical Pain Scale (0: no pain, 10: maximum pain) assesses the intensity of pain.
Time frame: Changes from Baseline, and 10 weeks
Quality of Life (SF-36)
Time frame: Changes from Baseline, and 10 weeks
Pittsburgh Quality of Sleep Questionnaire
Time frame: Changes from Baseline, and 10 weeks
Beck Inventory for Depression
Time frame: Changes from Baseline, and 10 weeks
Fibromyalgia Impact Questionnaire (FIQ)
Time frame: Changes from Baseline, and 10 weeks
Hospital Anxiety Depression Scale (HADS)
Time frame: Changes from Baseline, and 10 weeks
State-Trait Anxiety Inventory (STAI)
Time frame: Changes from Baseline, and 10 weeks
McGill Pain Questionnaire
Time frame: Changes from Baseline, and 10 weeks
Fatigue Impact Scale
Time frame: Changes from Baseline, and 10 weeks
Pain Pressure
Time frame: Changes from Baseline, and 10 weeks
Schöber Test
Time frame: Changes from Baseline, and 10 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Widespread pain index
Time frame: Changes from Baseline, and 10 weeks
Symptom severity score
Time frame: Changes from Baseline, and 10 weeks
Measurement Finger-Floor
Time frame: symptom severity scale